首页ASRT • NASDAQ
add
Assertio Holdings Inc
昨日收盘价
$0.81
当日价格范围
$0.81 - $0.83
年度波幅
$0.74 - $1.80
市值
7862.23万 USD
平均交易量
58.68万
市盈率
-
股息率
-
主要交易所
NASDAQ
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 2920.40万 | -18.03% |
经营支出 | 2440.20万 | -18.13% |
净收入 | -292.10万 | 98.96% |
净利润率 | -10.00 | 98.73% |
每股收益 | 0.03 | 200.00% |
息税折旧摊销前利润 | 396.30万 | -56.54% |
有效税率 | -1.53% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 8857.90万 | 15.21% |
总资产 | 2.76亿 | -27.37% |
负债总额 | 1.45亿 | -22.27% |
权益总额 | 1.31亿 | — |
发行在外的股份 | 9547.78万 | — |
市净率 | 0.59 | — |
资产回报率 | -2.47% | — |
资本回报率 | -4.00% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -292.10万 | 98.96% |
来自运营的现金 | -3.50万 | -101.36% |
投资现金 | -670.90万 | -261.90% |
融资现金 | -1.00万 | 0.00% |
现金净变动 | -675.40万 | -200.61% |
自由现金流 | 90.09万 | 99.64% |
简介
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
CEO
成立时间
1995
员工数量
53
